Results for: S2000-025測試 💫 S2000-025學習筆記 🌵 S2000-025最新題庫資源 👱 透過➡ www.newdumpspdf.com ️⬅️搜索➡ S2000-025 ️⬅️免費下載考試資料S2000-025考題資源

Polypharmacy common in MS patients

…(27.7%) and antidepressants (26.6%). Use of contraceptives was higher in the non-polypharmacy group (15.0% vs. 8.7%). Polypharmacy was more common in patients with comorbidities, both in the inpatient group (87.4% vs. 61.0% with no comorbidity) and in the outpatient group (46.2% vs. 11.8% with no comorbidity). Specific comorbidities in this study were not provided. A meta-analysis reported the most prevalent comorbid conditions in MS patients were…

Phase III trials in neurology – 2018 in review

…s ASA 75 mg, clopidogrel 75 mg and dipyridamole 200 mg BID. The primary outcome was the combined incidence and severity of any recurrent stroke (ischaemic or haemorrhagic) or TIA within 90 days. The trial was stopped early. No difference was seen with intensive antiplatelet therapy compared to the other regimens, but the intensive regimen was associated with more bleeding and severe bleeding events. The conclusion was that triple-therapy antiplate…

Record number of FDA drug approvals in 2018

…cond drug for Dravet syndrome, Diacomit (stiripentol, Biocodex) for use in combination with clobazam. Diacomit was approved in Canada in 2012 as an add-on to clobazam and valproate in patients with severe myoclonic epilepsy in infancy (SMEI) and Dravet syndrome. Another FDA first was Onpattro (patisiran, Alnylam Pharmaceuticals) – the first small interfering RNA (siRNA) agent and the first therapy to receive approval for the treatment of polyneuro…

Rare cases of stroke reported with alemtuzumab

…mas et al. Neurol Neuroimmunol Neuroinflamm 2016;3:e228; free full text at www.ncbi.nlm.nih.gov/pmc/articles/pmid/27213173/). A cytokine storm was reported in the one patient who died of hemorrhagic stroke. Cytokine syndrome may manifest clinically as pyrexia, headache, malaise and urticarial rash, and may be associated with a transient worsening of neurological symptoms (Moreau et al. Brain 1996;119:225-237). The incidence of cytokine release syn…

Improving QoL in patients with schizophrenia

…ore relevant in gauging a patient’s life improvement. Finally, there is a need for further treatment research into patients with psychosis comorbid with SUD so we can provide improved outcomes in this complex patient group. Dr. MacEwan is Clinical Professor, Department of Psychiatry, University of British Columbia, Vancouver, Canada….